18 th International Webinar on

 Pharmacovigilance & Drug Safety

Pharmacovigilance 2020

Theme: New Era of Pharmacovigilance

Meetings International is announcing 18th International Conference on Pharmacovigilance & Drug Safety (Pharmacovigilance 2020) which is scheduled at Dubai, UAE during July 25th. This Pharmacovigilance conference focuses on “New Era of Pharmacovigilance”.
 
Scientific Sessions of Pharmacovigilance includes Pharmacovigilance Significance & Scope, Clinical Pharmacy and its Role in Treatment, Pre-Clinical and Clinical Trials, Biosimilars Pharmacovigilance and Risk Management, Clinical drug toxicity and biomarkers, Pharmacovigilance for herbal medicines.
 
Dubai is leading city of United Arab Emirates, as well as famous city in the world. The destinations which make Dubai special are Burj Khalifa, Burj Al Arab Jumeirah Beach, Dubai Palm Beach, Jumeirah Mosque, Dubai Creek, Dubai Mall, Dubai Museum, Dubai Aquarium.

 

Scientific Sessions :

Session 1.Pharmacovigilance Significance & Scope

Concept of Pharmacovigilance and its Significance enhances the impact of pharmacovigilance on patient welfare and public health and to know what is pharmacovigilance. . The Role of Pharma industries in the improvement of pharmacovigilance system is very crucial to maintain the safety data, Detection and Evaluation of drug safety signals through manual and medical devices reporting.

Session 2.Clinical Pharmacy and its Role in Treatment

Clinical pharmacy is a branch of pharmacy that involves the provision of patient care with the use of medications to optimize the health outcomes of patients. This includes promoting wellness and preventing disease. The practice of clinical pharmacy embraces pharmaceutical care philosophy. Clinical pharmacists are the experts in the therapeutic use of medicines in the healthcare team.

Session 3.Biosimilars Pharmacovigilance and Risk Management

Biosimilars cannot be authorized based on the same requirements that apply to generic medicines. Despite the fact that the biosimilar and reference drug can show similar efficacy, the biosimilar may exhibit different safety profile in terms of nature, seriousness or incidence of adverse reactions.

Session 4 .Clinical Drug Toxicity

Pharmacology intersects with toxicology when the physiological response to a drug is an adverse effect. A poison is any substance, including any drug that has the capacity to harm a living organism. Poisoning generally implies that damaging physiological effects result from exposure to pharmaceuticals, illicit drugs, or chemicals.

Session 5.Biomakers

Biomarkers is defined as characteristic that is measured as an indicator of normal biological processes, pathogenic processes, or responses to an exposure or intervention, including therapeutic interventions.In medicine, a biomarker can be a traceable substance that is introduced into an organism as a means to examine organ function or other aspects of health.It can also be a substance whose detection indicates a particular disease state, for example, the presence of an antibody may indicate an infection.

Session 6.Pharmacovigilance for Herbal Medicines

Pharmacovigilance is essential for developing reliable information on the safety of herbal medicines as used in Europe and the US. The existing systems were developed for synthetic medicines and require some modification to address the specific differences of medicinal herbs.

 Session 7.Pharmacoepidemiology

Pharmacoepidemiology is the study of the uses and effects of drugs in well-defined populations.To accomplish this study, pharmacoepidemiology borrows from both pharmacology and epidemiology. Thus, pharmacoepidemiology is the bridge between both pharmacology and epidemiology.

Session 8.Serotonin Pharmacology

The pharmacology of serotonin (5-hydroxytryptamine or 5-HT) in the gut has been the centre of intense interest and research for several decades. ... In the gut, 5-HT is an important mucosal signalling molecule targeting enterocytes, smooth muscle cells, and enteric neurones.

Session 9.Pharmacogenetics and Pharmacogenomics

Pharmacogenetics usually refers to how variation in one single gene influences the response to a single drug. Pharmacogenomics is a broader term, which studies how all of the genes (the genome) can influence responses to drugs.

Session 10.Nano Pharmaceuticals

Nano pharmaceuticals represent an emerging field where the sizes of the drug particle or a therapeutic delivery system work at the Nano scale. In the pharmaceutical industry, a long standing issue is the difficulty of delivering the appropriate dose of a particular active agent to specific disease site.

Market Research:

Introduction

“Pharmacovigilance Market “research report highlights existing dynamics and growths during the forecast period 2019-2024. The report incorporates detailed analysis of the market development drivers as well as the preventing factors in the Pharmacovigilance market. The scope of the report covers an extensive estimation pertaining to the winning essentials and participant schemes through a presentation of the segmentation of market in the report.

Scope and importance:

Pharmacovigilance is the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The focus of pharmacovigilance is on ADR (adverse drug reactions) and drug toxicity. The pharmacovigilance market comprises of all types of adverse events reporting conducted during clinical trials in hospitals, pharmacies, and other healthcare sectors.

The Global Universities :

USA:

  • Texas Tech university
  • New jersy institute of Technology
  • MCPHS university
  • University of missouri
  • University of Illinois at Chicago
  • University at Buffalo,The state University of Newyork
  • Southern Illinois University Edwarsville
  • Southern Illinois University Carbondale
  • University of Arizona
  • Western New England University

Europe:

  • Copenhagen University
  • University of Nottingham
  • University college London
  • Leiden University
  • Karolinska Institute
  • The University of Manchester
  • Cardiff University
  • University college cork
  • Medway school of pharmacy
  • University of East Anglia

Asia pacific:

  • National University of Singapore
  • University of Melbourne
  • Hong Kong University of Science and Technology
  • University of Hong Kong
  • Peking University
  • Australian National University   
  • The University of Tokyo
  • Tsinghua University
  • University of Queensland
  • Kyoto University

Middle east:

  • Qatar University
  • King Abdulaziz University KAU
  • United Arab Emirates University
  • King saud University
  • Alfaisal University
  • Labanese American University
  • University of Sharjah
  • Kuwait University
  • Ajman University
  • Umm Al Quara University

 

Research centers  around the Globe:

  • Arbutus Biopharma
  • Anogen
  • Antibe Therapeutics
  • Acceleron Pharma.
  • ABER Pharmaceuticals, LLC
  • Abraxis BioScience, Inc
  • Takeda Pharmaceutical Co Ltd
  • Daiichi Sankyo Co Ltd
  • Mitsubishi Tanabe Pharma Corp
  • Neopharma

 

Meetings International is announcing Young Scientist Awards through 18th International Conference on Pharmacovigilence & Drug Safety (Pharmacovigilence 2020) which is scheduled at Dubai, UAE during August 26-27, 2020. This Pharmacovigilence conference focuses on “Contemporary researches on Pharmacovigilence”.

Pharmacovigilence 2020 and upcoming conferences will recognise participants who have significantly added value to the scientific community of environmental science and provide them outstanding Young Scientist Awards. The Young Scientist Award will provide a strong professional development opportunity for young researches by meeting experts to exchange and share their experiences at our international conferences.

Pharmacovigilence 2020 focuses mainly on Clinical Trials, Drug Safety, Drug Delivery. Pharmacovigilence conference operating committee is providing a platform for all the budding young researchers, young investigators, post-graduate/Master students, PhD. students and trainees to showcase their research and innovation.

Eligibility:

Young Scientists, faculty members, post-doctoral fellows, PhD scholars and bright Final Year MSc and M.Phil. candidates. Persons from Scientific Industry can also participate.

Benefits: The Young Scientist Feature is a platform to promote young researchers in their respective area by giving them a chance to present their achievements and future perspectives.

  • Acknowledgement as YRF Awardee
  • Promotion on the conference website, Young Researcher Awards and certificates
  • Link on the conference website
  • Recognition on Meetings Int. Award Page
  • Chances to coordinate with partners around the world
  • Research work can be published in the relevant journal without any publication fee

Criteria:

  • All presented abstracts will automatically be considered for the Award.
  • All the presentation will be evaluated in the conference venue
  • All the awards will be selected by the judges of the award category
  • The winners of the Young Scientist Award will receive award certificate.
  • The awards will be assessed as far as plan and format, intelligence, argumentation and  approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.

Guidelines:

  • All submissions must be in English.
  • The topic must fit into scientific sessions of the conference
  • Each individual participant is allowed to submit maximum 2 papers
  • Abstract must be submitted online as per the given abstract template
  • Abstracts must be written in Times New Roman and font size will be 12
  • Abstract must contain title, name, affiliation, country, speakers biography, recent photograph, image and reference

Conditions of Acceptance:

To receive the award, the awardee must submit the presentation for which the award is given, for publication at the website, along with author permission. Failure to submit the PPT, and permission within the designated timeframe will result in forfeiture of award.

Award Announcements:

Official announcement of the recipients will occur after the completion of Pharmacovigilence Conference.

 

18th International Conference on Pharmacovigilence & Drug Safety provides liability to all the global emirates to grow your business globally and sell your Research Materials, pharmaceuticals, Antibodies, Clinical Reagents, Chemicals, Instruments.  Breathe life into your products and make moment brand mindfulness with a pennant advertisement arrangement. Make your pennant intuitive to guide individuals to where you need them to go.

Meetings International is providing opportunity to advertise and connect with the experts and leaders across the world. 3+ Million Website Visitors, 40000+ Conference Website Visitors and 1000+ Sessions which confirm the outstanding pool of new users and visitors creating a platform to build your market place globally. Meetings International helps you to connect with global clients anywhere at any time via our unrivalled, worldwide professionals reach. Start promoting your brand today, basically browse our immense scope of custom fitted, multi-channel publicizing and sponsorship alternatives across print and computerized stages and select the geology of your intended interest group.

We maintain high quality and ethical standards in event industry, which makes us unique and better than the rest. Advertisement banner must be provided by the advertising company and must be in the jpg or jpeg format. The banner must be of high resolution and must not have copyright infringement.

For further queries, connect our conference manager at pharmacovigilence@annualmeetings.net; sponsor@meetingsint.com

You can also connect us via WhatsApp: +65 3158 1626 / + 44 7482 874377

  • Pharmacovigilance Significance & Scope
  • Clinical Pharmacy and its Role in Treatment
  • Biosimilars Pharmacovigilance and Risk Management
  • Clinical Drug Toxicity
  • Biomakers
  • Pharmacovigilance for Herbal Medicines
  • Pharmacoepidemiology
  • Serotonin Pharmacology
  • Pharmacogenetics and Pharmacogenomics
  • Nano Pharmaceuticals

2 Organizing Committee Members

4 Renowned Speakers

Frank Orlowski

American Cancer Society
USA

Dr.Syed Zaferuddin

Manager and Global Deputy QP for Pharmacovigilance (Medical Affairs Dept.)
UAE

Mr.Abbas S.Kabir

St. John’s University
USA

Dr.Carolle Laure Kpoumie

University of the Sorbonne
France

Media Partners & Collaborations

Media Partner

Media Partner

Media Partner

Media Partner